Status:
RECRUITING
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
Luxembourg Institute of Health
Research Center for Clinical Neuroimmunology and Neuroscience Basel
Conditions:
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Eligibility:
All Genders
18+ years
Brief Summary
This prospective cohort study is part of the Clinnova programme and aims to (i) identify clinical imaging and omics characteristics associated with early Multiple Sclerosis (MS) and with transitioning...
Detailed Description
Multiple Sclerosis (MS) is a chronic disease of the central nervous system that causes a range of neurological symptoms, such as cognitive issues, fatigue, vision problems, and muscle weakness. There ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age ≥18
- Participants are willing and able to comply with the protocol, including undergoing data and samples collection as well as study visits and examinations.
- Signed informed consent form
- In possession of a Healios+Me app compatible smartphone (iOS/Android)
- Corrected close visual acuity of ≥0.5
- Hand motor skills sufficient for using a smartphone
- Ability to follow the study procedures
- Diagnosed with MS according to the revised McDonald criteria 2017, all clinical forms inclusive (clinically isolated syndrome, RRMS, SPMS, PPMS) AND early disease stages (\< 3 years) OR transitioning phase to progressive disease as evaluated based on Expanded Disability Status Scale (EDSS).
- Enrolled in the SMSC at University Hospital Basel
- There are no specific exclusion criteria.
Exclusion
Key Trial Info
Start Date :
December 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2029
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06526364
Start Date
December 10 2024
End Date
June 1 2029
Last Update
December 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)
Basel, Switzerland, 4031